<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629146</url>
  </required_header>
  <id_info>
    <org_study_id>GabA01</org_study_id>
    <nct_id>NCT02629146</nct_id>
  </id_info>
  <brief_title>Analgesic Effects of Midazolam in Human Volunteers</brief_title>
  <acronym>GabA01</acronym>
  <official_title>A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled, Three-way Cross-over Study of the Analgesic Effects of Midazolam Versus Placebo With Fentanyl as an Active Control in Human Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wilhelminenspital Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Akron Molecules AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wilhelminenspital Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates analgesic properties of midazolam compared to placebo and fentanyl. Each
      participant will receive all three drugs (midazolam, fentanyl, placebo) on three different
      occasions (study visits) and the effect on different pain stimuli will be tested.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain ratings (0-100) to a suprathreshold heat pain stimulus</measure>
    <time_frame>3.5 Minutes after end of infusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in pain ratings to a suprathreshold electrical pain stimulus</measure>
    <time_frame>3.5 Minutes after end of infusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase of pressure pain thresholds (kPa)</measure>
    <time_frame>Up until 23 Minutes after end of infusion</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Analgesic Drugs</condition>
  <condition>Antinociceptive Agents</condition>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: Midazolam (experimental)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug: Isotonic saline (placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: Fentanyl (active comparator)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <arm_group_label>Midazolam</arm_group_label>
    <other_name>Dormicum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <arm_group_label>Fentanyl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic saline</intervention_name>
    <arm_group_label>Isotonic saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female volunteers

          -  18-40 years old

          -  healthy

          -  body mass index between 5th and 85th percentile

          -  Caucasian

          -  non smoker or moderate smoker (&lt;10 cigarettes per day)

          -  able to understand, write, and read German

        Exclusion Criteria:

          -  acute or chronic pain condition (except for mild day-to-day pain on &lt;5 days/month)

          -  previous (up to 5 days preceding the study) or current medications prescription or
             over-the-counter, especially analgesics

          -  symptoms of a clinically relevant illness in the 2 weeks before the first study day

          -  hypertension

          -  any known psychiatric condition

          -  abuse of alcoholic beverages, drug abuse

          -  known positive human immunodeficiency virus status

          -  any known medical condition which may interact with study medication, study
             objectives, or compliance of subject with study tasks

          -  participation in a clinical trial in the 4 weeks preceding the study

          -  known allergy against Midazolam

          -  known allergy against Fentanyl

          -  pregnancy or breast-feeding

          -  unable or unwilling to give informed consent

          -  unable or unwilling to follow investigator's instructions

          -  unable or unwilling to comply with study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Burkhard Gustorff, Prof.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wilhelminenspital Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Schmerzdiagnostik / Clinical Research Unit</name>
      <address>
        <city>Vienna</city>
        <zip>1190</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2015</study_first_posted>
  <last_update_submitted>March 10, 2016</last_update_submitted>
  <last_update_submitted_qc>March 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wilhelminenspital Vienna</investigator_affiliation>
    <investigator_full_name>Burkhard Gustorff</investigator_full_name>
    <investigator_title>Univ.Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>Midazolam</keyword>
  <keyword>Fentanyl</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

